Anwar, Andira I.
Byrne, Sean
Sharma, Akanksha
Sands, Scott
Wellman, Andrew
Redeker, Nancy S.
Yaggi, Henry
Zinchuk, Andrey V. http://orcid.org/0000-0003-0488-9778
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL102321, HL132093, HL159259)
Article History
Received: 3 April 2024
Revised: 10 June 2024
Accepted: 28 June 2024
First Online: 12 July 2024
Declarations
:
: The protocol for the reported study was approved by Yale University IRB.
: Andira I. Anwar – no conflicts of interest. Sean Byrne – no conflicts of interest. Akanksha Sharma – no conflicts of interest. Scott Sands* is a consultant for NOX Medical, Apnimed, Lily, LingualFlex, Inspire, Respicardia, Forepont, Achaemenid. He received Industry grants from Prosomnus, Dynaflex and Apnimed. He has academic grants from National Institutes of Health (NIH) National Heart Lung and Blood Institute (NHLBI), American Academy of Sleep Medicine Foundation and American Heart Association. Andrew Wellman* works as a consultant for Apnimed, SomniFix and Nox, and has received grants from SomniFix and Sanofi. He has a financial interest in Apnimed, a company developing pharmacological therapies for sleep apnea. He has academic grants from NIH. Nancy S. Redeker – no conflicts of interest. Henry Yaggi - receives grant funding from NIH NHLBI. Henry Yaggi - receives grant funding from NIH NHLBI. Andrey V. Zinchuk has a financial interest in Restful Robotics, a company developing robotic solutions to positive airway pressure therapy and receives grant funding from NIH NHLBI as well as Parker B Francis Fellowship award. <b>*</b> The interests of Drs. Sands and Wellman are managed by Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies.